Farmacéuticos Comunitarios. 2020 Jul 22; 12(3):21-50 DOI: 10.33620/FC.2173-9218.(2020/Vol12).003.04

Treatment program for diabetic and prediabetic patients in community pharmacy: ‘DayBTS’

Reyes Estévez D1, Díaz Martín AM2, Angulo Castro FJ1, Pérez García S3, Revilla Calvo MV2, Miranda Saavedra FA4, Valerón Bergh VJ2, Domínguez del Río Boada B5
1. Farmacéutico comunitario 2. Farmacéutica del Colegio Oficial de Farmacéuticos de Santa Cruz de Tenerife (COF SCTFE) 3. Farmacéutica comunitaria. Doctora en Farmacología por la Universidad de Valladolid 4. Farmacéutico comunitario. Secretario del COF SCTFE 5. Farmacéutico comunitario. Presidente de la delegación canaria de SEFAC
Reyes D, Díaz AM, Angulo FJ, Pérez S, Revilla MV, Miranda FA, Valerón VJ, Domínguez B. Programa de atención a pacientes diabéticos y prediabéticos en farmacia comunitaria: 'DayBTS'. Farmacéuticos Comunitarios. 2020 Jul 22; 12 (3): 21-50 DOI: 10.33620/FC.2173-9218.(2020/Vol12).003.04
Abstract : 

Reason: in Spain there are 6 million people with diabetes. The Canary Islands are 1.86 percentage points above the national average. Although information on diabetes has improved, the number of patients continues to increase. Community pharmacists can play a significant role thanks to their academic training as healthcare providers specialized in medications and their proximity to patients. For this reason, it is important to have projects for the design and standardization of pharmacotherapeutic monitoring services in diabetes, besides a multidisciplinary approach.

Objective: design of a treatment service for diabetic and prediabetic patients in community pharmacy called DayBTS.

Target population: older people who visit the pharmacy and meet at least one of the following requirements: treatment with antidiabetic medication, are overweight or obese, arterial hypertension or hypercholesterolemia, with family history of diabetes or who ask for the service directly.

Structure: series of visits in four phases. Initial phase, includes 5 visits. Continuation phase, 2 visits for monitoring and new doubts or issues. The activities to perform in general are as follows: diabetes education, measurement of clinical variables (blood glucose, body mass index, glycosylated hemoglobin, glycemic patterns), economic variables (visits at primary care, acute care, number of medications used) and human variables (treatment compliance, quality of life, knowledge of diabetes).

Expected cost: the cost per visit is estimated according to: type of visit, material supplies and pharmaceutical staff time. Between 5.95€ (prediabetic patient) and 20.90€ (diabetic patient) with cost proposed 7.44€ and 26.13€ for a 20 % margin. The cost of the complete service would be 88.31-111€ (Prediabetes-Diabetes).

Article download link: